EXAS+76.44%12.9%
NTRA+125.82%11.5%
GH+153.69%10.0%
NEO+78.60%8.5%
QGEN-5.11%7.2%
TEM-30.22%6.5%
VCYT+24.82%6.5%
CSTL+42.48%5.7%
GRAL+86.43%5.7%
LH+13.11%5.0%
ABT-25.42%4.4%
ILMN+174.31%4.3%
MYGN-45.74%4.3%
DGX+27.21%4.2%
PSNL+86.53%2.2%
BDX+23.61%1.0%
As of Oct 9, 2026, 4:27 AM ET
MedTech Long '26: Diagnostics & Early Detection Constituents
Exact Sciences CorporationEXAS | 12.9% | 0.00% | 0.00% | 0.00% | 0.00% | 3.30% | 1.48% | 135.44% | 76.44% | 53.00% | 11.98% | $20.03B |
Natera, Inc.NTRA | 11.5% | -1.21% | -5.10% | 18.31% | -4.33% | 70.58% | 87.84% | 172.90% | 125.82% | 196.21% | 242.59% | $55.97B |
Guardant Health, Inc.GH | 10.0% | -1.65% | -6.64% | 1.71% | -5.26% | 62.09% | 76.32% | 280.69% | 153.69% | 686.51% | 58.69% | $22.22B |
NeoGenomics, Inc.NEO | 8.5% | 0.31% | -16.95% | -9.29% | -9.90% | 36.22% | 62.97% | 70.06% | 78.60% | 19.20% | -61.64% | $411.6M |
Qiagen N.V.QGEN | 7.2% | -0.58% | -1.07% | 4.78% | 5.92% | -0.98% | -10.58% | 11.27% | -5.11% | 2.16% | -13.00% | $9.18B |
Tempus AI, Inc.TEM | 6.5% | -1.52% | -18.57% | 13.05% | -9.44% | 17.32% | 30.10% | 38.87% | -30.22% | 44.09% | 72.12% | $12.14B |
Veracyte, Inc.VCYT | 6.5% | 1.02% | -3.60% | -0.59% | -1.34% | 3.56% | 19.16% | 44.71% | 24.82% | 30.23% | 4.98% | $3.48B |
Castle Biosciences, Inc.CSTL | 5.7% | 2.15% | -6.18% | 4.33% | -4.38% | -13.34% | 14.00% | 66.96% | 42.48% | 12.33% | -45.01% | $1.03B |
GRAIL Inc.GRAL | 5.7% | -0.22% | -0.02% | 71.15% | 0.04% | 54.94% | 149.13% | 407.31% | 86.43% | 920.08% | 552.61% | $5.69B |
Labcorp Holdings Inc.LH | 5.0% | 0.71% | 1.50% | -2.15% | 3.15% | 25.24% | 8.67% | 32.93% | 13.11% | 48.19% | 36.05% | $25.76B |
Abbott LaboratoriesABT | 4.4% | -0.24% | -2.47% | -6.41% | 1.86% | -20.99% | -15.35% | -23.95% | -25.42% | -11.59% | -9.53% | $170.43B |
Illumina, Inc.ILMN | 4.3% | -1.19% | -2.70% | 29.06% | -0.43% | 101.72% | 96.76% | 223.12% | 174.31% | 89.44% | -33.66% | $40.03B |
Myriad Genetics, Inc.MYGN | 4.3% | -1.87% | -0.94% | 31.66% | 3.45% | -31.71% | -8.89% | -52.27% | -45.74% | -83.82% | -86.40% | $396.7M |
Quest Diagnostics IncorporatedDGX | 4.2% | 1.68% | -2.87% | -1.97% | -0.12% | 33.01% | 8.92% | 38.09% | 27.21% | 55.89% | 74.56% | $25.48B |
Personalis, Inc.PSNL | 2.2% | 0.38% | -1.59% | -2.07% | -0.68% | 101.76% | 77.26% | 351.12% | 86.53% | 208.25% | -13.93% | $1.71B |
Becton, Dickinson and CompanyBDX | 1.0% | 1.44% | -0.59% | 1.64% | 2.63% | 19.78% | 3.55% | 4.41% | 23.61% | 0.61% | 7.16% | $50.35B |
| Theme return | — | -0.26% | -4.92% | 8.29% | -2.22% | 34.40% | 41.78% | 127.96% | 63.39% | 132.02% | 108.58% | — |
| Average | 6.2% | -0.05% | -4.24% | 9.58% | -1.18% | 28.91% | 37.58% | 112.60% | 50.41% | 141.92% | 49.85% | $27.77B |
| Median | 5.7% | -0.11% | -2.58% | 1.67% | -0.28% | 22.51% | 16.58% | 55.83% | 34.85% | 46.14% | 6.07% | $16.08B |
| Std Dev | 3.1% | 1.20% | 5.56% | 19.58% | 4.33% | 39.18% | 46.46% | 132.76% | 63.11% | 262.71% | 148.97% | $40.67B |
| Min | 1.0% | -1.87% | -18.57% | -9.29% | -9.90% | -31.71% | -15.35% | -52.27% | -45.74% | -83.82% | -86.40% | $396.7M |
| Max | 12.9% | 2.15% | 1.50% | 71.15% | 5.92% | 101.76% | 149.13% | 407.31% | 174.31% | 920.08% | 552.61% | $170.43B |
| % Positive Tickers | 43.75% | 6.25% | 56.25% | 37.50% | 75.00% | 81.25% | 87.50% | 75.00% | 87.50% | 56.25% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort